Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | S1PR5 | Q9H228 | 11/20 | 0.48 |
| ▸ | S1PR1 | P21453 | 7/20 | 0.48 |
| ▸ | S1PR3 | Q99500 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27269821 | 0.97 | NPC1 (0.47) | MEN1KMT2AS1PR5S1PR1S1PR3 | |
| SCHEMBL27166219 | 0.92 | MEN1 (0.46) | MEN1KMT2AS1PR5S1PR1S1PR3 | |
| SCHEMBL27299235 | 0.92 | MEN1 (0.46) | MEN1KMT2AS1PR5S1PR1S1PR3 | |
| SCHEMBL27166230 | 0.91 | MEN1 (0.47) | MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL27146634 | 0.91 | MEN1 (0.47) | MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL27166229 | 0.90 | KDM4E (0.40) | MEN1KMT2AS1PR5S1PR1S1PR3 | |
| SCHEMBL9031416 | 0.90 | ITGB3 (0.43) | MEN1KMT2AS1PR5S1PR1S1PR3 | |
| SCHEMBL27166254 | 0.89 | KDM4E (0.41) | MEN1KMT2AS1PR5S1PR1S1PR3 | |
| SCHEMBL27166241 | 0.89 | KDM4E (0.41) | MEN1KMT2AS1PR5S1PR1S1PR3 | |
| SCHEMBL30823371 | 0.88 | ITGB3 (0.45) | S1PR5S1PR1S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584251-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | Bayer Aktiengesellschaft (DE) | 2025-07-16 | — | — | EP | claimed |
| WO-2024052549-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-14 | — | — | WO | claimed |
| EP-4584251-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | Bayer Aktiengesellschaft (DE) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024052549-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024052549-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-14 | — | — | WO | disclosed |
| EP-4335840-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | Bayer Aktiengesellschaft (DE) | 2024-03-13 | — | — | EP | disclosed |